English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

De Quervain’s tenosynovitis is one of the most common forms of stenosing tenosynovitis encountered by hand surgeons. This tenosynovitis was first described by Fritz de Quervain (1). De Quervain’s tenosynovitis causes radial wrist pain that increases with activity (2). Steroid injection into the tendon sheath is the primary treatment in uncomplicated cases (3). Although steroid injection is common, complications, such as subcutaneous atrophy, fat necrosis, weakening or rupture of tendons, and depigmentation, have been reported after this treatment regimen (4-7). Surgical release, which provides a precise and permanent solution in most cases, is considered for steroid-refractory patients and for patients whose complaints last over 6 months (8, 9). Since the rate of recurrence and complication is lower after surgical treatment, it has been widely used currently. In the present study, we aimed to evaluate the efficacy of open surgery versus steroid injection in patients with De Quervain’s tenosynovitis.

Steroid Injection Versus Open Surgery in the Treatment of De Quervain’s Tenosynovitis